Exosens: Availability of documents and information relating to the Combined General Meeting of 23 May 2025
PRESS RELEASEMÉRIGNAC, FRANCE – 30 APRIL 2025 EXOSENS ANNOUNCES THE AVAILABILITY OF DOCUMENTS…
More races, more excitement for Nordic Combined fans at Trondheim 2025 WSC
Mar 18, 2025 - Among the success stories of the Trondheim 2025…
Combined General Meeting of January 31, 2025
Paris, France – January 31, 2025 – The Combined Annual General Meeting of…
Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024)
November 09, 2024 13:00 ET | Source: Replimune Group Inc Oral presentation…